Diabetes, Obesity and Metabolism

Cover image for Diabetes, Obesity and Metabolism

November 2013

Volume 15, Issue 11

Pages i–i, 967–1063

  1. ISSUE INFORMATION

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW ARTICLES
    4. ORIGINAL ARTICLES
    5. RESEARCH LETTER
    6. NEWS AND VIEWS
    1. Issue Information (page i)

      Version of Record online: 7 OCT 2013 | DOI: 10.1111/dom.1689

  2. REVIEW ARTICLES

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW ARTICLES
    4. ORIGINAL ARTICLES
    5. RESEARCH LETTER
    6. NEWS AND VIEWS
    1. You have free access to this content
    2. Type 2 diabetes sits in a chair (pages 987–992)

      T. P. J. Solomon and J. P. Thyfault

      Version of Record online: 22 APR 2013 | DOI: 10.1111/dom.12105

  3. ORIGINAL ARTICLES

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW ARTICLES
    4. ORIGINAL ARTICLES
    5. RESEARCH LETTER
    6. NEWS AND VIEWS
    1. You have full text access to this OnlineOpen article
      Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P) (pages 1000–1007)

      M. Pinget, R. Goldenberg, E. Niemoeller, I. Muehlen-Bartmer, H. Guo and R. Aronson

      Version of Record online: 26 MAY 2013 | DOI: 10.1111/dom.12121

    2. The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus (pages 1008–1012)

      J. I. Blomster, C. K. Chow, S. Zoungas, M. Woodward, A. Patel, N. R. Poulter, M. Marre, S. Harrap, J. Chalmers and G. S. Hillis

      Version of Record online: 11 JUN 2013 | DOI: 10.1111/dom.12122

    3. GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus (pages 1013–1021)

      R. L. Dobbins, S. P. Shearn, R. L. Byerly, F. F. Gao, K. M. Mahar, A. Napolitano, G. J. Nachbaur and A. -C. Le Monnier de Gouville

      Version of Record online: 12 JUN 2013 | DOI: 10.1111/dom.12132

    4. Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes? (pages 1022–1028)

      J. Nagendran, G. Y. Oudit, J. A. Bakal, P. E. Light, J. R. B. Dyck and F. A. McAlister

      Version of Record online: 3 JUN 2013 | DOI: 10.1111/dom.12126

    5. You have full text access to this OnlineOpen article
    6. You have full text access to this OnlineOpen article
      Diabetes and gout: efficacy and safety of febuxostat and allopurinol (pages 1049–1055)

      M. A. Becker, P. A. MacDonald, B. J. Hunt and R. L. Jackson

      Version of Record online: 12 JUN 2013 | DOI: 10.1111/dom.12135

  4. RESEARCH LETTER

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW ARTICLES
    4. ORIGINAL ARTICLES
    5. RESEARCH LETTER
    6. NEWS AND VIEWS
    1. Differences between men and women in the regulation of adipose 11β-HSD1 and in its association with adiposity and insulin resistance (pages 1056–1060)

      J. deSchoolmeester, J. Palming, T. Persson, M. J. Pereira, E. Wallerstedt, H. Brown, D. Gill, F. Renström, M. Lundgren, M. K. Svensson, A. Rees and J. W. Eriksson

      Version of Record online: 20 JUN 2013 | DOI: 10.1111/dom.12137

  5. NEWS AND VIEWS

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW ARTICLES
    4. ORIGINAL ARTICLES
    5. RESEARCH LETTER
    6. NEWS AND VIEWS
    1. News and Views (pages 1061–1063)

      Iskandar Idris

      Version of Record online: 7 OCT 2013 | DOI: 10.1111/dom.12215

SEARCH

SEARCH BY CITATION